Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021 10 0
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021 11 2
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 9 0
Itolizumab Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021 4 0
Teicoplanin Potential treatment - pre-clinical evidence Experimental Antiviral Mar/06/2021 2 1
Saquinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 10 1
Acarbose Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/12/2020 3 0
Ursolic acid Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020 2 0